Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)

This study has been completed.
Sponsor:
Collaborator:
Kuopio University Hospital
Information provided by (Responsible Party):
Laurantis Pharma, Ltd.
ClinicalTrials.gov Identifier:
NCT01476332
First received: November 10, 2011
Last updated: May 15, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)